195 related articles for article (PubMed ID: 36652154)
1. Impact of silencing eEF2K expression on the malignant properties of chordoma.
Aydemir E; Tüysüz EC; Bayrak ÖF; Tecimel D; Hızlı-Deniz AA; Şahin F
Mol Biol Rep; 2023 Apr; 50(4):3011-3022. PubMed ID: 36652154
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanism for the Control of Eukaryotic Elongation Factor 2 Kinase by pH: Role in Cancer Cell Survival.
Xie J; Mikolajek H; Pigott CR; Hooper KJ; Mellows T; Moore CE; Mohammed H; Werner JM; Thomas GJ; Proud CG
Mol Cell Biol; 2015 May; 35(10):1805-24. PubMed ID: 25776553
[TBL] [Abstract][Full Text] [Related]
3. Eukaryotic elongation factor 2 (eEF2) kinase/eEF2 plays protective roles against glucose deprivation-induced cell death in H9c2 cardiomyoblasts.
Kameshima S; Okada M; Yamawaki H
Apoptosis; 2019 Apr; 24(3-4):359-368. PubMed ID: 30737648
[TBL] [Abstract][Full Text] [Related]
4. Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia.
Moore CE; Mikolajek H; Regufe da Mota S; Wang X; Kenney JW; Werner JM; Proud CG
Mol Cell Biol; 2015 May; 35(10):1788-804. PubMed ID: 25755286
[TBL] [Abstract][Full Text] [Related]
5. Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells.
Xie CM; Liu XY; Sham KW; Lai JM; Cheng CH
Autophagy; 2014 Sep; 10(9):1495-508. PubMed ID: 24955726
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target.
Karakas D; Ozpolat B
J Mol Med (Berl); 2020 Jun; 98(6):775-787. PubMed ID: 32377852
[TBL] [Abstract][Full Text] [Related]
7. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.
Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH
Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587
[TBL] [Abstract][Full Text] [Related]
8. Repression of eEF2K transcription by NF-κB tunes translation elongation to inflammation and dsDNA-sensing.
Bianco C; Thompson L; Mohr I
Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22583-22590. PubMed ID: 31636182
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells.
Zhu H; Yang X; Liu J; Zhou L; Zhang C; Xu L; Qin Q; Zhan L; Lu J; Cheng H; Sun X
Cell Stress Chaperones; 2015 Mar; 20(2):217-20. PubMed ID: 25248493
[TBL] [Abstract][Full Text] [Related]
10. Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer.
Fu LL; Xie T; Zhang SY; Liu B
Apoptosis; 2014 Oct; 19(10):1527-31. PubMed ID: 25023961
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling.
Wang X; Regufe da Mota S; Liu R; Moore CE; Xie J; Lanucara F; Agarwala U; Pyr Dit Ruys S; Vertommen D; Rider MH; Eyers CE; Proud CG
Mol Cell Biol; 2014 Nov; 34(22):4088-103. PubMed ID: 25182533
[TBL] [Abstract][Full Text] [Related]
12. Investigating Eukaryotic Elongation Factor 2 Kinase/Eukaryotic Translation Elongation Factor 2 Pathway Regulation and Its Role in Protein Synthesis Impairment during Disuse-Induced Skeletal Muscle Atrophy.
Vilchinskaya N; Lim WF; Belova S; Roberts TC; Wood MJA; Lomonosova Y
Am J Pathol; 2023 Jun; 193(6):813-828. PubMed ID: 36871751
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles.
Kenney JW; Moore CE; Wang X; Proud CG
Adv Biol Regul; 2014 May; 55():15-27. PubMed ID: 24853390
[TBL] [Abstract][Full Text] [Related]
14. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
15. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.
Leprivier G; Remke M; Rotblat B; Dubuc A; Mateo AR; Kool M; Agnihotri S; El-Naggar A; Yu B; Somasekharan SP; Faubert B; Bridon G; Tognon CE; Mathers J; Thomas R; Li A; Barokas A; Kwok B; Bowden M; Smith S; Wu X; Korshunov A; Hielscher T; Northcott PA; Galpin JD; Ahern CA; Wang Y; McCabe MG; Collins VP; Jones RG; Pollak M; Delattre O; Gleave ME; Jan E; Pfister SM; Proud CG; Derry WB; Taylor MD; Sorensen PH
Cell; 2013 May; 153(5):1064-79. PubMed ID: 23706743
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic Elongation Factor 2 Kinase a Pharmacological Target to Regulate Protein Translation Dysfunction in Neurological Diseases.
Beretta S; Gritti L; Verpelli C; Sala C
Neuroscience; 2020 Oct; 445():42-49. PubMed ID: 32088293
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.
Liu R; Proud CG
Acta Pharmacol Sin; 2016 Mar; 37(3):285-94. PubMed ID: 26806303
[TBL] [Abstract][Full Text] [Related]
18. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K
Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509
[TBL] [Abstract][Full Text] [Related]
19. Coupled activation and degradation of eEF2K regulates protein synthesis in response to genotoxic stress.
Kruiswijk F; Yuniati L; Magliozzi R; Low TY; Lim R; Bolder R; Mohammed S; Proud CG; Heck AJ; Pagano M; Guardavaccaro D
Sci Signal; 2012 Jun; 5(227):ra40. PubMed ID: 22669845
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase.
Hizli AA; Chi Y; Swanger J; Carter JH; Liao Y; Welcker M; Ryazanov AG; Clurman BE
Mol Cell Biol; 2013 Feb; 33(3):596-604. PubMed ID: 23184662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
